Epilepsy emergencies: Diagnosis and management

Neurologic Clinics

Volumn 30, Issue 1, 2012, Pages 11-41

  Foreman, Brandon ^a   Hirsch, Lawrence J ^b  

^a NEUROLOGICAL INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coma; Critical care; Epilepsy; Intensive care unit; Nonconvulsive seizures; Seizures; Status epilepticus

Indexed keywords

ACICLOVIR; AMPICILLIN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; CEFTRIAXONE; DESFLURANE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; GABAPENTIN; HARKOSERIDE; ISOFLURANE; KETAMINE; LIDOCAINE; LORAZEPAM; MAGNESIUM; MIDAZOLAM; OXCARBAZEPINE; PENTOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; PROPOFOL; THIOPENTAL; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN;

BODY TEMPERATURE DISORDER; BRAIN ATROPHY; CARDIAC DEPRESSION; CLINICAL FEATURE; COMATOSE PATIENT; CONVULSIVE STATUS EPILEPTICUS; CRITICALLY ILL PATIENT; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC STATE; HALLUCINATION; HEART ARRHYTHMIA; HUMAN; HYPERAMMONEMIA; HYPOTENSION; INDUCED HYPOTHERMIA; KETOGENIC DIET; LISTERIOSIS; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LOADING DRUG DOSE; LUNG DISEASE; MAINTENANCE THERAPY; MEDICAL ASSESSMENT; MENINGOENCEPHALITIS; MENTAL DISEASE; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; MULTIPLE ORGAN FAILURE; MUSIC THERAPY; MYOCARDIAL DEPRESSION; MYOCARDIAL DISEASE; MYOCLONIC STATUS EPILEPTICUS; NAUSEA; NEUROPROTECTION; NEUROTOXICITY; NONCONVULSIVE EPILEPTIC STATE; NONHUMAN; ORGAN TRANSPLANTATION; PANCREATITIS; PARKINSONISM; POIKILOTHERMY; PREGNANCY; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; PSYCHOSIS; PURPLE GLOVE SYNDROME; RASH; REFRACTORY STATUS EPILEPTICUS; RESPIRATION DEPRESSION; RESPIRATORY SUPPRESSION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SKIN DISEASE; SUBARACHNOID HEMORRHAGE; TACHYPHYLAXIS; THROMBOCYTOPENIA; TISSUE NECROSIS; VASODILATATION;

COMA; CRITICAL ILLNESS; ELECTROENCEPHALOGRAPHY; EMERGENCIES; EMERGENCY MEDICINE; HUMANS; PROGNOSIS; SEIZURES; STATUS EPILEPTICUS;

EID: 84856248083     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2011.09.005     Document Type: Review

References (160)

1. Pallin D.J., Goldstein J.N., Moussally J.S., et al. Seizure visits in US emergency departments: epidemiology and potential disparities in care. Int J Emerg Med 2008, 1(2):97-105.
2. Fisher R.S., van Emde Boas W., Blume W., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46(4):470-472.
3. Theodore W.H., Porter R.J., Albert P., et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology 1994, 44(8):1403-1407.
4. Hauser W.A., Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia 2008, 49(Suppl 1):8-12.
5. Martindale J.L., Goldstein J.N., Pallin D.J. Emergency department seizure epidemiology. Emerg Med Clin North Am 2011, 29(1):15-27.
6. Gastaut H. Classification of status epilepticus. Adv Neurol 1983, 34:15-35.
7. DeLorenzo R.J., Garnett L.K., Towne A.R., et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 1999, 40(2):164-169.
8. Jenssen S., Gracely E.J., Sperling M.R. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia 2006, 47(9):1499-1503.
9. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993, 270(7):854-859.
10. Pellock J.M., Marmarou A., DeLorenzo R. Time to treatment in prolonged seizure episodes. Epilepsy Behav 2004, 5(2):192-196.
11. Lowenstein D.H., Bleck T., Macdonald R.L. It's time to revise the definition of status epilepticus. Epilepsia 1999, 40(1):120-122.
12. Hirsch L.J., Claassen J. The current state of treatment of status epilepticus. Curr Neurol Neurosci Rep 2002, 2(4):345-356.
13. Shorvon S. The definition, classification and frequency of NCSE. In: Walker M, Cross H, Smith S, etal, editors. Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports. Epileptic Disord 2005;7(3):253-96.
14. Chong D.J., Hirsch L.J. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. JClin Neurophysiol 2005, 22(2):79-91.
15. Chin R.F., Neville B.G., Scott R.C. Asystematic review of the epidemiology of status epilepticus. Eur J Neurol 2004, 11(12):800-810.
16. DeLorenzo R.J., Hauser W.A., Towne A.R., et al. Aprospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46(4):1029-1035.
17. Penberthy L.T., Towne A., Garnett L.K., et al. Estimating the economic burden of status epilepticus to the health care system. Seizure 2005, 14(1):46-51.
18. Treiman D.M., Meyers P.D., Walton N.Y., et al. Acomparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. NEngl J Med 1998, 339(12):792-798.
19. Claassen J., Hirsch L.J. Refractory status epilepticus. Atlas of video-EEG monitoring 2011, 473-505. McGraw-Hill, New York. 1st edition. J.I. Sirven, J.M. Stern (Eds.).
20. Holtkamp M., Othman J., Buchheim K., et al. A" malignant" variant of status epilepticus. Arch Neurol 2005, 62(9):1428-1431.
21. Claassen J., Mayer S.A., Kowalski R.G., et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004, 62(10):1743-1748.
22. Abend N.S., Gutierrez-Colina A.M., Topjian A.A., et al. Nonconvulsive seizures are common in critically ill children. Neurology 2011, 76(12):1071-1077.
23. Claassen J., Jette N., Chum F., et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007, 69(13):1356-1365.
24. DeLorenzo R.J., Waterhouse E.J., Towne A.R., et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998, 39(8):833-840.
25. Jette N., Claassen J., Emerson R.G., et al. Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol 2006, 63(12):1750-1755.
26. Jordan K.G. Neurophysiologic monitoring in the neuroscience intensive care unit. Neurol Clin 1995, 13(3):579-626.
27. Kilbride R.D., Costello D.J., Chiappa K.H. How seizure detection by continuous electroencephalographic monitoring affects the prescribing of antiepileptic medications. Arch Neurol 2009, 66(6):723-728.
28. Oddo M., Carrera E., Claassen J., et al. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009, 37(6):2051-2056.
29. Pandian J.D., Cascino G.D., So E.L., et al. Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome. Arch Neurol 2004, 61(7):1090-1094.
30. Privitera M., Hoffman M., Moore J.L., et al. EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res 1994, 18(2):155-166.
31. Towne A.R., Waterhouse E.J., Boggs J.G., et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000, 54(2):340-345.
32. Vespa P.M., Nuwer M.R., Nenov V., et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. JNeurosurg 1999, 91(5):750-760.
33. Vespa P.M., O'Phelan K., Shah M., et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003, 60(9):1441-1446.
34. Jordan K.G. Continuous EEG and evoked potential monitoring in the neuroscience intensive care unit. JClin Neurophysiol 1993, 10(4):445-475.
35. Jordan K.G., Hirsch L.J. In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia 2006, 47(Suppl 1):41-45.
36. Engel J. Aproposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42(6):796-803.
37. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993, 34(3):453-468.
38. Annegers J.F., Hauser W.A., Lee J.R., et al. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995, 36(4):327-333.
39. Aminoff M.J., Simon R.P. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980, 69(5):657-666.
40. Bleck T.P. Less common etiologies of status epilepticus. Epilepsy Curr 2010, 10(2):31-33.
41. Cooper A.D., Britton J.W., Rabinstein A.A. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol 2009, 66(12):1505-1509.
42. Delanty N., French J.A., Labar D.R., et al. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure 2001, 10(2):116-119.
43. Drislane F.W., Lopez M.R., Blum A.S., et al. Detection and treatment of refractory status epilepticus in the intensive care unit. JClin Neurophysiol 2008, 25(4):181-186.
44. Hesdorffer D.C., Logroscino G., Cascino G., et al. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998, 50(3):735-741.
45. Holtkamp M., Othman J., Buchheim K., et al. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. JNeurol Neurosurg Psychiatry 2005, 76(4):534-539.
46. Lowenstein D.H., Alldredge B.K. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993, 43(3 Pt 1):483-488.
47. Towne A.R., Pellock J.M., Ko D., et al. Determinants of mortality in status epilepticus. Epilepsia 1994, 35(1):27-34.
48. Hesdorffer D.C., Benn E.K., Cascino G.D., et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 2009, 50(5):1102-1108.
49. Fountain N.B. Status epilepticus: risk factors and complications. Epilepsia 2000, 41(Suppl 2):S23-S30.
50. Logroscino G., Hesdorffer D.C., Cascino G., et al. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997, 38(12):1344-1349.
51. Meldrum B.S., Vigouroux R.A., Brierley J.B. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973, 29(2):82-87.
52. Chen J.W., Wasterlain C.G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006, 5(3):246-256.
53. Costello D.J., Cole A.J. Treatment of acute seizures and status epilepticus. JIntensive Care Med 2007, 22(6):319-347.
54. Drislane F.W., Blum A.S., Lopez M.R., et al. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009, 50(6):1566-1571.
55. Fountain N.B., Lothman E.W. Pathophysiology of status epilepticus. JClin Neurophysiol 1995, 12(4):326-342.
56. Mazarati A.M., Baldwin R.A., Sankar R., et al. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998, 814(1-2):179-185.
57. Sisodiya S.M., Thom M. Widespread upregulation of drug-resistance proteins in fatal human status epilepticus. Epilepsia 2003, 44(2):261-264.
58. Wasterlain C.G., Mazarati A.M., Naylor D., et al. Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus. Epilepsia 2002, 43(Suppl 5):20-29.
59. Claassen J., Lokin J.K., Fitzsimmons B.F., et al. Predictors of functional disability and mortality after status epilepticus. Neurology 2002, 58(1):139-142.
60. Hesdorffer D.C., Logroscino G., Cascino G., et al. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol 1998, 44(6):908-912.
61. Shneker B.F., Fountain N.B. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003, 61(8):1066-1073.
62. Young G.B., Jordan K.G., Doig G.S. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996, 47(1):83-89.
63. Vespa P., Prins M., Ronne-Engstrom E., et al. Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. JNeurosurg 1998, 89(6):971-982.
64. DeGiorgio C.M., Heck C.N., Rabinowicz A.L., et al. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 1999, 52(4):746-749.
65. Vespa P.M., Miller C., McArthur D., et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 2007, 35(12):2830-2836.
66. Vespa P.M., McArthur D.L., Xu Y., et al. Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology 2010, 75(9):792-798.
67. Vignatelli L., Rinaldi R., Baldin E., et al. Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. JNeurol 2008, 255(2):197-204.
68. Waterhouse E.J., Vaughan J.K., Barnes T.Y., et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 1998, 29(3):175-183.
69. Dennis L.J., Claassen J., Hirsch L.J., et al. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery 2002, 51(5):1136-1143. [discussion: 1144].
70. Williams A.J., Tortella F.C., Lu X.M., et al. Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia. JPharmacol Exp Ther 2004, 311(1):220-227.
71. Krsek P., Mikulecka A., Druga R., et al. Long-term behavioral and morphological consequences of nonconvulsive status epilepticus in rats. Epilepsy Behav 2004, 5(2):180-191.
72. Vespa P. Continuous EEG monitoring for the detection of seizures in traumatic brain injury, infarction, and intracerebral hemorrhage: "to detect and protect" JClin Neurophysiol 2005, 22(2):99-106.
73. Koubeissi M., Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 2007, 69(9):886-893.
74. Mayer S.A., Claassen J., Lokin J., et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59(2):205-210.
75. Novy J., Logroscino G., Rossetti A.O. Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51(2):251-256.
76. Waterhouse E.J., Garnett L.K., Towne A.R., et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 1999, 40(6):752-758.
77. Alldredge B.K., Gelb A.M., Isaacs S.M., et al. Acomparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. NEngl J Med 2001, 345(9):631-637.
78. Muayqil T., Rowe B.H., Ahmed S.N. Treatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room. Epileptic Disord 2007, 9(1):43-50.
79. Prasad K., Al-Roomi K., Krishnan P.R., et al. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2005, 4. CD003723.
80. McIntyre J., Robertson S., Norris E., et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005, 366(9481):205-210.
81. Silbergleit R, Lowenstein D, Durkalski V. A double-blind randomized clinical trial of the efficacy of IM midazolam versus IV lorazepam in the pre-hospital treatment of status epilepticus by paramedics. In: Clinicaltrials.gov. Bethesda (MD): National Library of Medicine (US); 2000 [cited 6 Jun 2011]. Available at: Accessed June 6, 2011. NLM Identifier: 00809146. https://clinitaltrials.gov/ct2/show/NCT00809146.
82. Nocero M., Svoronos A., Arif H., et al. Nasal midazolam as a seizure-aborting therapy and comparison with oral and rectal benzodiazepines in adults. Neurology Suppl 2011, 76(9):A1-A816. [abstract S855.006].
83. Abou Khaled K.J., Hirsch L.J. Updates in the management of seizures and status epilepticus in critically ill patients. Neurol Clin 2008, 26(2):385-408. viii.
84. Boggs J.G., Painter J.A., DeLorenzo R.J. Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res 1993, 14(1):87-94.
85. Legriel S., Bruneel F., Dalle L., et al. Recurrent takotsubo cardiomyopathy triggered by convulsive status epilepticus. Neurocrit Care 2008, 9(1):118-121.
86. Manno E.M., Pfeifer E.A., Cascino G.D., et al. Cardiac pathology in status epilepticus. Ann Neurol 2005, 58(6):954-957.
87. Seow S.C., Lee Y.P., Teo S.G., et al. Takotsubo cardiomyopathy associated with status epilepticus. Eur J Neurol 2008, 15(6):e46.
88. Willmore L.J. Epilepsy emergencies: the first seizure and status epilepticus. Neurology 1998, 51(5 Suppl 4):S34-S38.
89. Arif H., Hirsch L.J. Treatment of status epilepticus. Semin Neurol 2008, 28(3):342-354.
90. Leppik I.E., Derivan A.T., Homan R.W., et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983, 249(11):1452-1454.
91. Claassen J., Hirsch L.J., Mayer S.A. Treatment of status epilepticus: a survey of neurologists. JNeurol Sci 2003, 211(1-2):37-41.
92. Agarwal P., Kumar N., Chandra R., et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007, 16(6):527-532.
93. Aiguabella M., Falip M., Villanueva V., et al. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study. Seizure 2011, 20(1):60-64.
94. Berning S., Boesebeck F., van Baalen A., et al. Intravenous levetiracetam as treatment for status epilepticus. JNeurol 2009, 256(10):1634-1642.
95. Claassen J., Hirsch L.J., Emerson R.G., et al. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001, 57(6):1036-1042.
96. Claassen J., Hirsch L.J., Emerson R.G., et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43(2):146-153.
97. Eue S., Grumbt M., Muller M., et al. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav 2009, 15(4):467-469.
98. Kellinghaus C., Berning S., Immisch I., et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011, 123(2):137-141.
99. Knake S., Gruener J., Hattemer K., et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. JNeurol Neurosurg Psychiatry 2008, 79(5):588-589.
100. Misra U.K., Kalita J., Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006, 67(2):340-342.
101. Rossetti A.O., Milligan T.A., Vulliemoz S., et al. Arandomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011, 14(1):4-10.
102. Rossetti A.O., Reichhart M.D., Schaller M.D., et al. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 2004, 45(7):757-763.
103. Camilo O., Goldstein L.B. Seizures and epilepsy after ischemic stroke. Stroke 2004, 35(7):1769-1775.
104. Burneo J.G., Anandan J.V., Barkley G.L. Aprospective study of the incidence of the purple glove syndrome. Epilepsia 2001, 42(9):1156-1159.
105. DeToledo J.C., Ramsay R.E. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs. Drug Saf 2000, 22(6):459-466.
106. Zeller J.A., Schlesinger S., Runge U., et al. Influence of valproate monotherapy on platelet activation and hematologic values. Epilepsia 1999, 40(2):186-189.
107. Sinha S., Naritoku D.K. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000, 55(5):722-724.
108. Fattouch J., Di Bonaventura C., Casciato S., et al. Intravenous levetiracetam as first-line treatment of status epilepticus in the elderly. Acta Neurol Scand 2010, 121(6):418-421.
109. Vasile B., Rasulo F., Candiani A., et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003, 29(9):1417-1425.
110. Kapur J. Hippocampal neurons express GABA A receptor insensitive to diazepam in hyperexcitable conditions. Epilepsia 2000, 41(Suppl 6):S86-S89.
111. Rossetti A.O., Logroscino G., Bromfield E.B. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62(11):1698-1702.
112. Krishnamurthy K.B., Drislane F.W. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996, 37(9):863-867.
113. Meierkord H., Boon P., Engelsen B., et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010, 17(3):348-355.
114. Bauer L.A. Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology 1982, 32(5):570-572.
115. Sander J.W., Perucca E. Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management. Acta Neurol Scand Suppl 2003, 180:16-22.
116. Greenaway C., Ratnaraj N., Sander J.W., et al. Saliva and serum lacosamide concentrations in patients with epilepsy. Epilepsia 2011, 52(2):258-263.
117. Koubeissi M.Z., Mayor C.L., Estephan B., et al. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand 2011, 123(2):142-146.
118. Novy J., Rossetti A.O. Oral pregabalin as an add-on treatment for status epilepticus. Epilepsia 2010, 51(10):2207-2210.
119. Towne A.R., Garnett L.K., Waterhouse E.J., et al. The use of topiramate in refractory status epilepticus. Neurology 2003, 60(2):332-334.
120. Fisher A., Wang X., Cock H.R., et al. Synergism between topiramate and budipine in refractory status epilepticus in the rat. Epilepsia 2004, 45(11):1300-1307.
121. Hamer H.M., Knake S., Schomburg U., et al. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000, 54(1):230-232.
122. Borris D.J., Bertram E.H., Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res 2000, 42(2-3):117-122.
123. Martin B.S., Kapur J. Acombination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia 2008, 49(2):248-255.
124. Ubogu E.E., Sagar S.M., Lerner A.J., et al. Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav 2003, 4(1):70-75.
125. Mirsattari S.M., Sharpe M.D., Young G.B. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004, 61(8):1254-1259.
126. Fugate J.E., Burns J.D., Wijdicks E.F., et al. Prolonged high-dose isoflurane for refractory status epilepticus: is it safe?. Anesth Analg 2010, 111(6):1520-1524.
127. Pascual J., Ciudad J., Berciano J. Role of lidocaine (lignocaine) in managing status epilepticus. JNeurol Neurosurg Psychiatry 1992, 55(1):49-51.
128. Walker I.A., Slovis C.M. Lidocaine in the treatment of status epilepticus. Acad Emerg Med 1997, 4(9):918-922.
129. Visser N.A., Braun K.P., Leijten F.S., et al. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. JNeurol 2011, 258(2):218-222.
130. Loscher W. Mechanisms of drug resistance in status epilepticus. Epilepsia 2007, 48(Suppl 8):74-77.
131. Schmitt F.C., Dehnicke C., Merschhemke M., et al. Verapamil attenuates the malignant treatment course in recurrent status epilepticus. Epilepsy Behav 2010, 17(4):565-568.
132. Jambroszyk M., Tipold A., Potschka H. Add-on treatment with verapamil in pharmacoresistant canine epilepsy. Epilepsia 2011, 52(2):284-291.
133. Gouveia T.L., Scorza F.A., Silva M.J., et al. Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus. Epilepsy Behav 2011, 20(1):1-5.
134. Chu K., Jung K.H., Lee S.T., et al. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 2008, 49(10):1723-1732.
135. Corry J.J., Dhar R., Murphy T., et al. Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9(2):189-197.
136. Schmitt F.C., Buchheim K., Meierkord H., et al. Anticonvulsant properties of hypothermia in experimental status epilepticus. Neurobiol Dis 2006, 23(3):689-696.
137. Kamel H., Cornes S.B., Hegde M., et al. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care 2010, 12(2):204-210.
138. Miranda M., Kuester G., Rios L., et al. Refractory nonconvulsive status epilepticus responsive to music as an add-on therapy: a second case. Epilepsy Behav 2010, 19(3):539-540.
139. Neal E.G., Chaffe H., Schwartz R.H., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008, 7(6):500-506.
140. Wusthoff C.J., Kranick S.M., Morley J.F., et al. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia 2010, 51(6):1083-1085.
141. Ma X., Liporace J., O'Connor M.J., et al. Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res 2001, 46(1):33-38.
142. Costello D.J., Simon M.V., Eskandar E.N., et al. Efficacy of surgical treatment of de novo, adult-onset, cryptogenic, refractory focal status epilepticus. Arch Neurol 2006, 63(6):895-901.
143. Lhatoo S.D., Alexopoulos A.V. The surgical treatment of status epilepticus. Epilepsia 2007, 48(Suppl 8):61-65.
144. Fisher R., Salanova V., Witt T., et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010, 51(5):899-908.
145. Hamani C., Hodaie M., Chiang J., et al. Deep brain stimulation of the anterior nucleus of the thalamus: effects of electrical stimulation on pilocarpine-induced seizures and status epilepticus. Epilepsy Res 2008, 78(2-3):117-123.
146. Robakis T.K., Hirsch L.J. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 2006, 4(1):35-46.
147. Jordan K.G. Nonconvulsive status epilepticus in acute brain injury. JClin Neurophysiol 1999, 16(4):332-340. [discussion: 353].
148. Litt B., Wityk R.J., Hertz S.H., et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998, 39(11):1194-1202.
149. Orta D.S., Chiappa K.H., Quiroz A.Z., et al. Prognostic implications of periodic epileptiform discharges. Arch Neurol 2009, 66:985-991.
150. Jaitly R., Sgro J.A., Towne A.R., et al. Prognostic value of EEG monitoring after status epilepticus: a prospective adult study. JClin Neurophysiol 1997, 14(4):326-334.
151. Nei M., Lee J.M., Shanker V.L., et al. The EEG and prognosis in status epilepticus. Epilepsia 1999, 40(2):157-163.
152. Foreman B., Claassen J., Hirsch L.J. Acontrolled study of 202 patients with generalized periodic discharges (GPDs): relationship to seizures and outcome 2011, American Clinical Neurophysiology Society, New Orleans (LA).
153. Fountain N.B., Waldman W.A. Effects of benzodiazepines on triphasic waves: implications for nonconvulsive status epilepticus. JClin Neurophysiol 2001, 18(4):345-352.
154. Brenner R.P. Is it status?. Epilepsia 2002, 43(Suppl 3):103-113.
155. Ono S., Chida K., Fukaya N., et al. Dysphasia accompanied by periodic lateralized epileptiform discharges. Intern Med 1997, 36(1):59-61.
156. Hirsch L.J., Brenner R.P., Drislane F.W., et al. The ACNS subcommittee on research terminology for continuous EEG monitoring: proposed standardized terminology for rhythmic and periodic EEG patterns encountered in critically ill patients. JClin Neurophysiol 2005, 22(2):128-135.
157. Wijdicks E.F., Plevak D.J., Wiesner R.H., et al. Causes and outcome of seizures in liver transplant recipients. Neurology 1996, 47(6):1523-1525.
158. Beach R.L., Kaplan P.W. Seizures in pregnancy: diagnosis and management. Int Rev Neurobiol 2008, 83:259-271.
159. EURAP Study Group Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006, 66(3):354-360.
160. Meador K., Reynolds M.W., Crean S., et al. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008, 81(1):1-13.